Laryngeal tuberculosis.
Krecicki
Tomasz
T
Departament of ENT, Medical University in Wroclaw, Poland. krecicki@orl.am.wroc.pl
Zalesska-Krecicka
Maria
M
Zatonski
Tomasz
T
Jankowska
Renata
R
Skrzydlewska-Kaczmarek
Beata
B
D000111:Acetylcysteine / Q000627:therapeutic use; D000328:Adult; D000995:Antitubercular Agents / Q000627:therapeutic use; D004825:Epiglottis / Q000382:microbiology / Q000473:pathology; D004977:Ethambutol / Q000627:therapeutic use; D005260:Female; D006102:Granuloma, Laryngeal / Q000473:pathology; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D009161:Mycobacterium / Q000302:isolation & purification*; D012293:Rifampin / Q000627:therapeutic use; D014387:Tuberculosis, Laryngeal / Q000188:drug therapy / Q000473:pathology
D000995:Antitubercular Agents; D004977:Ethambutol; D007538:Isoniazid; D012293:Rifampin; D000111:Acetylcysteine